Letteratura
Pubblicazioni scientifiche nazionali e internazionali d’interesse pneumologico.
Jackson DJ, Burhan H, Rupani H, Pfeffer PE, Clifton IJ, Faruqi S, et al. Overcoming Barriers to Remission in Severe Eosinophilic Asthma: Two-Year Real-World Data With Benralizumab. Clin Exp Allergy. 2024 Oct;54(10):734-746. Available from: http://dx.doi.org/10.1111/cea.14544
Senna G, Latorre M, Bugiani M, Caminati M, Heffler E, Morrone D, et al. Sex Differences in Severe Asthma: Results From Severe Asthma Network in Italy-SANI. Allergy, Asthma & Immunology Research [Internet]. 2021;13(2):219. Available from: http://dx.doi.org/10.4168/aair.2021.13.2.219
Menzies-Gow A, Szefler SJ, Busse WW. The Relationship of Asthma Biologics to Remission for Asthma. The Journal of Allergy and Clinical Immunology: In Practice [Internet]. 2021 Mar;9(3):1090–8. Available from: http://dx.doi.org/10.1016/j.jaip.2020.10.035
Wang E, Wechsler ME, Tran TN, Heaney LG, Jones RC, Menzies-Gow AN, et al. Characterization of Severe Asthma Worldwide. Chest [Internet]. 2020 Apr;157(4):790–804. Available from: http://dx.doi.org/10.1016/j.chest.2019.10.053
Papi A, Blasi F, Canonica GW, Morandi L, Richeldi L, Rossi A. Treatment strategies for asthma: reshaping the concept of asthma management. Allergy, Asthma & Clinical Immunology [Internet]. 2020 Aug 15;16(1). Available from: http://dx.doi.org/10.1186/s13223-020-00472-8
Cloutier MM, Dixon AE, Krishnan JA, Lemanske RF, Pace W, Schatz M. Managing Asthma in Adolescents and Adults. JAMA [Internet]. 2020 Dec 8;324(22):2301. Available from: http://dx.doi.org/10.1001/jama.2020.21974
Lau A, Tarlo SM. Update on the Management of Occupational Asthma and Work-Exacerbated Asthma. Allergy, Asthma & Immunology Research [Internet]. 2019;11(2):188. Available from: http://dx.doi.org/10.4168/aair.2019.11.2.188
Neffen H, Chahuàn M, Hernández DD, Vallejo-Perez E, Bolivar F, Sánchez MH, et al. Key factors associated with uncontrolled asthma – the Asthma Control in Latin America Study. Journal of Asthma [Internet]. 2019 Mar 27;57(2):113–22. Available from: http://dx.doi.org/10.1080/02770903.2018.1553050
Busse WW. Biological treatments for severe asthma: A major advance in asthma care. Allergology International [Internet]. 2019 Apr;68(2):158–66. Available from: http://dx.doi.org/10.1016/j.alit.2019.01.004
Abdullah K, Zhu J, Gershon A, Dell S, To T. Effect of asthma exacerbation during pregnancy in women with asthma: a population-based cohort study. European Respiratory Journal [Internet]. 2019 Nov 26;55(2):1901335. Available from: http://dx.doi.org/10.1183/13993003.01335-2019
Boonpiyathad T, Sözener ZC, Satitsuksanoa P, Akdis CA. Immunologic mechanisms in asthma. Seminars in Immunology [Internet]. 2019 Dec;46:101333. Available from: http://dx.doi.org/10.1016/j.smim.2019.101333
Govoni M, Bassi M, Girardello L, Lucci G, Rony F, Charretier R, et al. CHF6523 data suggest that the phosphoinositide 3-kinase delta isoform is not a suitable target for the management of COPD. Respir Res. 2024 Oct 19;25(1):380. Available from: http://dx.doi.org/10.1186/s12931-024-02999-5
Watz H, Kirsten AM, Ludwig-Sengpiel A, Krüll M, Mroz RM, Georges G, et al. Effects of inhaled beclometasone dipropionate/formoterol fumarate/glycopyrronium vs. beclometasone dipropionate/formoterol fumarate and placebo on lung hyperinflation and exercise endurance in chronic obstructive pulmonary disease: a randomised controlled trial. Respir Res. 2024 Oct 17;25(1):378. Available from: http://dx.doi.org/10.1186/s12931-024-02993-x
Martinez FJ, Agusti A, Celli BR, Han MK, Allinson JP, Bhatt SP, et al. Treatment Trials in Young Patients with Chronic Obstructive Pulmonary Disease and Pre–Chronic Obstructive Pulmonary Disease Patients: Time to Move Forward. American Journal of Respiratory and Critical Care Medicine [Internet]. 2022 Feb 1;205(3):275–87. Available from: http://dx.doi.org/10.1164/rccm.202107-1663so
Iheanacho I, Zhang S, King D, Rizzo M, Ismaila AS. Economic Burden of Chronic Obstructive Pulmonary Disease (COPD): A Systematic Literature Review. International Journal of Chronic Obstructive Pulmonary Disease [Internet]. 2020 Feb;Volume 15:439–60. Available from: http://dx.doi.org/10.2147/copd.s234942
Young AL, Bragman FJS, Rangelov B, Han MK, Galbán CJ, Lynch DA, et al. Disease Progression Modeling in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine [Internet]. 2020 Feb 1;201(3):294–302. Available from: http://dx.doi.org/10.1164/rccm.201908-1600oc
Labaki WW, Rosenberg SR. Chronic Obstructive Pulmonary Disease. Annals of Internal Medicine [Internet]. 2020 Aug 4;173(3):ITC17–32. Available from: http://dx.doi.org/10.7326/aitc202008040
Lacasse Y, Sériès F, Corbeil F, Baltzan M, Paradis B, Simão P, et al. Randomized Trial of Nocturnal Oxygen in Chronic Obstructive Pulmonary Disease. New England Journal of Medicine [Internet]. 2020 Sep 17;383(12):1129–38. Available from: http://dx.doi.org/10.1056/nejmoa2013219
Bowerman KL, Rehman SF, Vaughan A, Lachner N, Budden KF, Kim RY, et al. Disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease. Nature Communications [Internet]. 2020 Nov 18;11(1). Available from: http://dx.doi.org/10.1038/s41467-020-19701-0
Bhatt SP, Washko GR, Hoffman EA, Newell JD, Bodduluri S, Diaz AA, et al. Imaging Advances in Chronic Obstructive Pulmonary Disease. Insights from the Genetic Epidemiology of Chronic Obstructive Pulmonary Disease (COPDGene) Study. American Journal of Respiratory and Critical Care Medicine [Internet]. 2019 Feb 1;199(3):286–301. Available from: http://dx.doi.org/10.1164/rccm.201807-1351so
Stockley RA, Halpin DMG, Celli BR, Singh D. Chronic Obstructive Pulmonary Disease Biomarkers and Their Interpretation. American Journal of Respiratory and Critical Care Medicine [Internet]. 2019 May 15;199(10):1195–204. Available from: http://dx.doi.org/10.1164/rccm.201810-1860so
Agustí A, Hogg JC. Update on the Pathogenesis of Chronic Obstructive Pulmonary Disease. Drazen JM, editor. New England Journal of Medicine [Internet]. 2019 Sep 26;381(13):1248–56. Available from: http://dx.doi.org/10.1056/nejmra1900475
Celli BR, Wedzicha JA. Update on Clinical Aspects of Chronic Obstructive Pulmonary Disease. Drazen JM, editor. New England Journal of Medicine [Internet]. 2019 Sep 26;381(13):1257–66. Available from: http://dx.doi.org/10.1056/nejmra1900500
Zhang K, Shi P, Li A, Zhou J, Chen M. Plasma genome-wide mendelian randomization identifies potentially causal genes in idiopathic pulmonary fibrosis. Respir Res. 2024 Oct 18;25(1):379. Available from: http://dx.doi.org/10.1186/s12931-024-03008-5
Zhou S, Cheng W, Liu Y, Gao H, Yu L, Zeng Y. MiR-125b-5p alleviates pulmonary fibrosis by inhibiting TGFβ1-mediated epithelial-mesenchymal transition via targeting BAK1. Respir Res. 2024 Oct 19;25(1):382. Available from: http://dx.doi.org/10.1186/s12931-024-03011-w
Moss BJ, Ryter SW, Rosas IO. Pathogenic Mechanisms Underlying Idiopathic Pulmonary Fibrosis. Annual Review of Pathology: Mechanisms of Disease [Internet]. 2022 Jan 24;17(1):515–46. Available from: http://dx.doi.org/10.1146/annurev-pathol-042320-030240
Raghu G, Remy-Jardin M, Richeldi L, Thomson CC, Inoue Y, Johkoh T, et al. Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. American Journal of Respiratory and Critical Care Medicine [Internet]. 2022 May 1;205(9):e18–47. Available from: http://dx.doi.org/10.1164/rccm.202202-0399st
Richeldi L, Azuma A, Cottin V, Hesslinger C, Stowasser S, Valenzuela C, et al. Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis. New England Journal of Medicine [Internet]. 2022 Jun 9;386(23):2178–87. Available from: http://dx.doi.org/10.1056/nejmoa2201737
Shenderov K, Collins SL, Powell JD, Horton MR. Immune dysregulation as a driver of idiopathic pulmonary fibrosis. Journal of Clinical Investigation [Internet]. 2021 Jan 19;131(2). Available from: http://dx.doi.org/10.1172/jci143226
Spagnolo P, Kropski JA, Jones MG, Lee JS, Rossi G, Karampitsakos T, et al. Idiopathic pulmonary fibrosis: Disease mechanisms and drug development. Pharmacology & Therapeutics [Internet]. 2021 Jun;222:107798. Available from: http://dx.doi.org/10.1016/j.pharmthera.2020.107798
Allen RJ, Guillen-Guio B, Oldham JM, Ma S-F, Dressen A, Paynton ML, et al. Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine [Internet]. 2020 Mar 1;201(5):564–74. Available from: http://dx.doi.org/10.1164/rccm.201905-1017oc
Phan THG, Paliogiannis P, Nasrallah GK, Giordo R, Eid AH, Fois AG, et al. Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis. Cellular and Molecular Life Sciences [Internet]. 2020 Nov 17;78(5):2031–57. Available from: http://dx.doi.org/10.1007/s00018-020-03693-7
Albert RK, Schwartz DA. Revealing the Secrets of Idiopathic Pulmonary Fibrosis. Phimister EG, editor. New England Journal of Medicine [Internet]. 2019 Jan 3;380(1):94–6. Available from: http://dx.doi.org/10.1056/nejmcibr1811639
Morse C, Tabib T, Sembrat J, Buschur KL, Bittar HT, Valenzi E, et al. Proliferating SPP1/MERTK-expressing macrophages in idiopathic pulmonary fibrosis. European Respiratory Journal [Internet]. 2019 Jun 20;54(2):1802441. Available from: http://dx.doi.org/10.1183/13993003.02441-2018
Ng B, Dong J, D’Agostino G, Viswanathan S, Widjaja AA, Lim W-W, et al. Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosis. Science Translational Medicine [Internet]. 2019 Sep 25;11(511). Available from: http://dx.doi.org/10.1126/scitranslmed.aaw1237
Waxman A, Restrepo-Jaramillo R, Thenappan T, Ravichandran A, Engel P, Bajwa A, et al. Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease. New England Journal of Medicine [Internet]. 2021 Jan 28;384(4):325–34. Available from: http://dx.doi.org/10.1056/nejmoa2008470
Roofeh D, Lin CJF, Goldin J, Kim GH, Furst DE, Denton CP, et al. Tocilizumab Prevents Progression of Early Systemic Sclerosis–Associated Interstitial Lung Disease. Arthritis & Rheumatology [Internet]. 2021 May 25;73(7):1301–10. Available from: http://dx.doi.org/10.1002/art.41668
Kapnadak SG, Raghu G. Lung transplantation for interstitial lung disease. European Respiratory Review [Internet]. 2021 Aug 3;30(161):210017. Available from: http://dx.doi.org/10.1183/16000617.0017-2021
Wong AW, Ryerson CJ, Guler SA. Progression of fibrosing interstitial lung disease. Respiratory Research [Internet]. 2020 Jan 29;21(1). Available from: http://dx.doi.org/10.1186/s12931-020-1296-3
Khanna D, Tashkin DP, Denton CP, Renzoni EA, Desai SR, Varga J. Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease. American Journal of Respiratory and Critical Care Medicine [Internet]. 2020 Mar 15;201(6):650–60. Available from: http://dx.doi.org/10.1164/rccm.201903-0563ci
Perelas A, Silver RM, Arrossi AV, Highland KB. Systemic sclerosis-associated interstitial lung disease. The Lancet Respiratory Medicine [Internet]. 2020 Mar;8(3):304–20. Available from: http://dx.doi.org/10.1016/s2213-2600(19)30480-1
Hunninghake GM, Quesada-Arias LD, Carmichael NE, Martinez Manzano JM, Poli De Frías S, Baumgartner MA, et al. Interstitial Lung Disease in Relatives of Patients with Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine [Internet]. 2020 May 15;201(10):1240–8. Available from: http://dx.doi.org/10.1164/rccm.201908-1571oc
Hoffmann-Vold A-M, Allanore Y, Alves M, Brunborg C, Airó P, Ananieva LP, et al. Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database. Annals of the Rheumatic Diseases [Internet]. 2020 Sep 28;80(2):219–27. Available from: http://dx.doi.org/10.1136/annrheumdis-2020-217455
Chen Z, Wang X, Ye S. Tofacitinib in Amyopathic Dermatomyositis–Associated Interstitial Lung Disease. New England Journal of Medicine [Internet]. 2019 Jul 18;381(3):291–3. Available from: http://dx.doi.org/10.1056/nejmc1900045
Jacob J, Hirani N, van Moorsel CHM, Rajagopalan S, Murchison JT, van Es HW, et al. Predicting outcomes in rheumatoid arthritis related interstitial lung disease. European Respiratory Journal [Internet]. 2018 Nov 28;53(1):1800869. Available from: http://dx.doi.org/10.1183/13993003.00869-2018
Robinson C. Pneumoconioses. Chapman SJ, Robinson GV, Shrimanker R, Turnbull CD, Wrightson JM, editors. Oxford Handbook of Respiratory Medicine [Internet]. 2021 Apr;425–34. Available from: http://dx.doi.org/10.1093/med/9780198837114.003.0036
Morimoto Y. Progress in educational program for diagnosis of occupational respiratory disease in Japan ‐Activity of Asian Intensive Reader of Pneumoconioses (AIR Pneumo)‐. Journal of Occupational Health [Internet]. 2020 Jan;62(1). Available from: http://dx.doi.org/10.1002/1348-9585.12156
Nogami S, J‐P NA, Nogami M, Matsui T, Ngatu NR, Tamura T, et al. Radiographic diagnosis of Pneumoconioses by AIR Pneumo‐trained physicians: Comparison with low‐dose thin‐slice computed tomography. Journal of Occupational Health [Internet]. 2020 Jan;62(1). Available from: http://dx.doi.org/10.1002/1348-9585.12141
Global and regional burden of chronic respiratory disease in 2016 arising from non-infectious airborne occupational exposures: a systematic analysis for the Global Burden of Disease Study 2016. Occupational and Environmental Medicine [Internet]. 2020 Feb 13;77(3):142–50. Available from: http://dx.doi.org/10.1136/oemed-2019-106013
Reid PT. Pneumoconioses. Shah PL, editor. Oxford Textbook of Medicine [Internet]. 2020 Mar;4219-C18.13.P116. Available from: http://dx.doi.org/10.1093/med/9780198746690.003.0420
Bell JL, Mazurek JM. Trends in Pneumoconiosis Deaths — United States, 1999–2018. MMWR Morbidity and Mortality Weekly Report [Internet]. 2020 Jun 12;69(23):693–8. Available from: http://dx.doi.org/10.15585/mmwr.mm6923a1
Farver C, Ghosh S, Gildea T, Sturgis CD. Pneumoconioses. Pulmonary Disease [Internet]. 2020;223–34. Available from: http://dx.doi.org/10.1007/978-3-030-47598-7_16
Kurth L, Halldin C, Laney AS, Blackley DJ. Causes of death among Federal Black Lung Benefits Program beneficiaries enrolled in Medicare, 1999–2016. American Journal of Industrial Medicine [Internet]. 2020 Sep 11;63(11):973–9. Available from: http://dx.doi.org/10.1002/ajim.23176
Perlman DM, Maier LA. Occupational Lung Disease. Medical Clinics of North America [Internet]. 2019 May;103(3):535–48. Available from: http://dx.doi.org/10.1016/j.mcna.2018.12.012
Blanc PD, Annesi-Maesano I, Balmes JR, Cummings KJ, Fishwick D, Miedinger D, et al. The Occupational Burden of Nonmalignant Respiratory Diseases. An Official American Thoracic Society and European Respiratory Society Statement. American Journal of Respiratory and Critical Care Medicine [Internet]. 2019 Jun 1;199(11):1312–34. Available from: http://dx.doi.org/10.1164/rccm.201904-0717st
Reinders S, Didden EM, Ong R. Survival, morbidity, and quality of life in pulmonary arterial hypertension patients: a systematic review of outcomes reported by population-based observational studies. Respir Res. 2024 Oct 16;25(1):373. Available from: http://dx.doi.org/10.1186/s12931-024-02994-w
Xu W, Janocha AJ, Erzurum SC. Metabolism in Pulmonary Hypertension. Annual Review of Physiology [Internet]. 2021 Feb 10;83(1):551–76. Available from: http://dx.doi.org/10.1146/annurev-physiol-031620-123956
Humbert M, McLaughlin V, Gibbs JSR, Gomberg-Maitland M, Hoeper MM, Preston IR, et al. Sotatercept for the Treatment of Pulmonary Arterial Hypertension. New England Journal of Medicine [Internet]. 2021 Apr 1;384(13):1204–15. Available from: http://dx.doi.org/10.1056/nejmoa2024277
Klok FA, Couturaud F, Delcroix M, Humbert M. Diagnosis of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. European Respiratory Journal [Internet]. 2020 Mar 17;55(6):2000189. Available from: http://dx.doi.org/10.1183/13993003.00189-2020
Savale L, Guimas M, Ebstein N, Fertin M, Jevnikar M, Renard S, et al. Portopulmonary hypertension in the current era of pulmonary hypertension management. Journal of Hepatology [Internet]. 2020 Jul;73(1):130–9. Available from: http://dx.doi.org/10.1016/j.jhep.2020.02.021
Papamatheakis DG, Poch DS, Fernandes TM, Kerr KM, Kim NH, Fedullo PF. Chronic Thromboembolic Pulmonary Hypertension. Journal of the American College of Cardiology [Internet]. 2020 Nov;76(18):2155–69. Available from: http://dx.doi.org/10.1016/j.jacc.2020.08.074
Delcroix M, Torbicki A, Gopalan D, Sitbon O, Klok FA, Lang I, et al. ERS statement on chronic thromboembolic pulmonary hypertension. European Respiratory Journal [Internet]. 2020 Dec 17;57(6):2002828. Available from: http://dx.doi.org/10.1183/13993003.02828-2020
Frost A, Badesch D, Gibbs JSR, Gopalan D, Khanna D, Manes A, et al. Diagnosis of pulmonary hypertension. European Respiratory Journal [Internet]. 2019 Jan;53(1):1801904. Available from: http://dx.doi.org/10.1183/13993003.01904-2018
Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. European Respiratory Journal [Internet]. 2019 Jan;53(1):1801913. Available from: http://dx.doi.org/10.1183/13993003.01913-2018
Vachiéry J-L, Tedford RJ, Rosenkranz S, Palazzini M, Lang I, Guazzi M, et al. Pulmonary hypertension due to left heart disease. European Respiratory Journal [Internet]. 2019 Jan;53(1):1801897. Available from: http://dx.doi.org/10.1183/13993003.01897-2018
Humbert M, Farber HW, Ghofrani H-A, Benza RL, Busse D, Meier C, et al. Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. European Respiratory Journal [Internet]. 2019 Mar 28;53(6):1802004. Available from: http://dx.doi.org/10.1183/13993003.02004-2018
Belperio JA, Shaikh F, Abtin FG, Fishbein MC, Weigt SS, Saggar R, et al. Diagnosis and Treatment of Pulmonary Sarcoidosis. JAMA [Internet]. 2022 Mar 1;327(9):856. Available from: http://dx.doi.org/10.1001/jama.2022.1570
Gupta R, Judson MA, Baughman RP. Management of Advanced Pulmonary Sarcoidosis. American Journal of Respiratory and Critical Care Medicine [Internet]. 2022 Mar 1;205(5):495–506. Available from: http://dx.doi.org/10.1164/rccm.202106-1366ci
Greaves SA, Atif SM, Fontenot AP. Adaptive Immunity in Pulmonary Sarcoidosis and Chronic Beryllium Disease. Frontiers in Immunology [Internet]. 2020 Mar 18;11. Available from: http://dx.doi.org/10.3389/fimmu.2020.00474
Rahaghi FF, Baughman RP, Saketkoo LA, Sweiss NJ, Barney JB, Birring SS, et al. Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis. European Respiratory Review [Internet]. 2020 Mar 20;29(155):190146. Available from: http://dx.doi.org/10.1183/16000617.0146-2019
Gupta R, Baughman RP. Advanced Pulmonary Sarcoidosis. Seminars in Respiratory and Critical Care Medicine [Internet]. 2020 Aug 10;41(05):700–15. Available from: http://dx.doi.org/10.1055/s-0040-1709495
Huitema MP, Mathijssen H, Mager JJ, Snijder RJ, Grutters JC, Post MC. Sarcoidosis-Associated Pulmonary Hypertension. Seminars in Respiratory and Critical Care Medicine [Internet]. 2020 Aug 10;41(05):659–72. Available from: http://dx.doi.org/10.1055/s-0040-1713615
Jeny F, Uzunhan Y, Lacroix M, Gille T, Brillet P-Y, Nardi A, et al. Predictors of mortality in fibrosing pulmonary sarcoidosis. Respiratory Medicine [Internet]. 2020 Aug;169:105997. Available from: http://dx.doi.org/10.1016/j.rmed.2020.105997
Trivieri MG, Spagnolo P, Birnie D, Liu P, Drake W, Kovacic JC, et al. Challenges in Cardiac and Pulmonary Sarcoidosis. Journal of the American College of Cardiology [Internet]. 2020 Oct;76(16):1878–901. Available from: http://dx.doi.org/10.1016/j.jacc.2020.08.042
Kouranos V, Ward S, Kokosi MA, Castillo D, Chua F, Judge EP, et al. Mixed Ventilatory Defects in Pulmonary Sarcoidosis. Chest [Internet]. 2020 Nov;158(5):2007–14. Available from: http://dx.doi.org/10.1016/j.chest.2020.04.074
Thillai M, Atkins CP, Crawshaw A, Hart SP, Ho L-P, Kouranos V, et al. BTS Clinical Statement on pulmonary sarcoidosis. Thorax [Internet]. 2020 Dec 2;76(1):4–20. Available from: http://dx.doi.org/10.1136/thoraxjnl-2019-214348
Sartorius V, Loi B, Vivalda L, Regiroli G, De La Rubia-Ortega S, Pezza L, et al. Effect of different CPAP levels on ultrasound-assessed lung aeration and gas exchange in neonates. Respir Res. 2024 Oct 17;25(1):375. Available from: http://dx.doi.org/10.1186/s12931-024-03010-x
Heijnen NFL, Hagens LA, Smit MR, Cremer OL, Ong DSY, van der Poll T, et al. Biological Subphenotypes of Acute Respiratory Distress Syndrome Show Prognostic Enrichment in Mechanically Ventilated Patients without Acute Respiratory Distress Syndrome. American Journal of Respiratory and Critical Care Medicine [Internet]. 2021 Jun 15;203(12):1503–11. Available from: http://dx.doi.org/10.1164/rccm.202006-2522oc
Spinelli E, Mauri T, Beitler JR, Pesenti A, Brodie D. Respiratory drive in the acute respiratory distress syndrome: pathophysiology, monitoring, and therapeutic interventions. Intensive Care Medicine [Internet]. 2020 Feb 3;46(4):606–18. Available from: http://dx.doi.org/10.1007/s00134-020-05942-6
Barrot L, Asfar P, Mauny F, Winiszewski H, Montini F, Badie J, et al. Liberal or Conservative Oxygen Therapy for Acute Respiratory Distress Syndrome. New England Journal of Medicine [Internet]. 2020 Mar 12;382(11):999–1008. Available from: http://dx.doi.org/10.1056/nejmoa1916431
Middleton EA, He X-Y, Denorme F, Campbell RA, Ng D, Salvatore SP, et al. Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood [Internet]. 2020 Sep 3;136(10):1169–79. Available from: http://dx.doi.org/10.1182/blood.2020007008
Combes A, Schmidt M, Hodgson CL, Fan E, Ferguson ND, Fraser JF, et al. Extracorporeal life support for adults with acute respiratory distress syndrome. Intensive Care Medicine [Internet]. 2020 Nov 2;46(12):2464–76. Available from: http://dx.doi.org/10.1007/s00134-020-06290-1
Matthay MA, Arabi YM, Siegel ER, Ware LB, Bos LDJ, Sinha P, et al. Phenotypes and personalized medicine in the acute respiratory distress syndrome. Intensive Care Medicine [Internet]. 2020 Nov 18;46(12):2136–52. Available from: http://dx.doi.org/10.1007/s00134-020-06296-9
Huppert L, Matthay M, Ware L. Pathogenesis of Acute Respiratory Distress Syndrome. Seminars in Respiratory and Critical Care Medicine [Internet]. 2019 Feb;40(01):031–9. Available from: http://dx.doi.org/10.1055/s-0039-1683996
Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome. New England Journal of Medicine [Internet]. 2019 May 23;380(21):1997–2008. Available from: http://dx.doi.org/10.1056/nejmoa1901686
Papazian L, Aubron C, Brochard L, Chiche J-D, Combes A, Dreyfuss D, et al. Formal guidelines: management of acute respiratory distress syndrome. Annals of Intensive Care [Internet]. 2019 Jun 13;9(1). Available from: http://dx.doi.org/10.1186/s13613-019-0540-9
Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome. New England Journal of Medicine [Internet]. 2019 Aug 22;381(8):785–8. Available from: http://dx.doi.org/10.1056/nejmc1908874
Fonti: PubMed, Microsoft Research, Semantic Scholar, Springer Nature